» Articles » PMID: 12488561

Role of RsmA in the Regulation of Swarming Motility and Virulence Factor Expression in Proteus Mirabilis

Overview
Journal J Med Microbiol
Specialty Microbiology
Date 2002 Dec 19
PMID 12488561
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Swarming by Proteus mirabilis involves differentiation of typical short vegetative rods into filamentous hyper-flagellated swarm cells that undergo cycles of rapid and co-ordinated population migration across surfaces and exhibit high levels of virulence gene expression. RsmA (repressor of secondary metabolites) and CsrA, its homologue in Escherichia coli, control many phenotypic traits, such as motility and pathogenesis in Erwinia species, glycogen biosynthesis, cell size and biofilm formation in Escherichia coli and swarming motility in Serratia marcescens. To investigate the role of RsmA in Proteus mirabilis, the rsmA gene from Proteus mirabilis (hereafter referred to as rsmA(Pm)) was cloned. RsmA(Pm) showed high sequence similarity to Escherichia coli CsrA and RsmA cloned from Erwinia carotovora subsp. carotovora, Serratia marcescens, Haemophilus influenzae and Bacillus subtilis and could complement an Escherichia coli csrA mutant in glycogen synthesis. A low-copy-number plasmid carrying rsmA(Pm) expressed from its native promoter caused suppression of swarming motility and expression of virulence factors in Proteus mirabilis. mRNA stability assays suggested that RsmA(Pm) inhibited virulence factor expression through promoting mRNA degradation. RsmA homologues cloned from Serratia marcescens and Erwinia carotovora subsp. carotovora could also inhibit swarming and virulence factor expression in Proteus mirabilis.

Citing Articles

Potential antivirulence activity of sub-inhibitory concentrations of ciprofloxacin against Proteus mirabilis isolates: an in-vitro and in-vivo study.

Elhosseini M, El-Banna T, Sonbol F, El-Bouseary M Ann Clin Microbiol Antimicrob. 2024; 23(1):48.

PMID: 38802894 PMC: 11131287. DOI: 10.1186/s12941-024-00704-4.


Relocating Glyceryl Trinitrate as an Anti-Virulence Agent against and : Insights from Molecular and In Vivo Investigations.

Nazeih S, Ali M, Halim A, Al-Lawati H, Abbas H, Al-Zharani M Microorganisms. 2023; 11(10).

PMID: 37894078 PMC: 10609227. DOI: 10.3390/microorganisms11102420.


Intracellular glycogen accumulation by human gut commensals as a niche adaptation trait.

Esteban-Torres M, Ruiz L, Rossini V, Nally K, Van Sinderen D Gut Microbes. 2023; 15(1):2235067.

PMID: 37526383 PMC: 10395257. DOI: 10.1080/19490976.2023.2235067.


Diminishing the Pathogenesis of the Food-Borne Pathogen by Low Doses of Sodium Citrate.

Khayat M, Elbaramawi S, Nazeih S, Safo M, Khafagy E, Ali M Biology (Basel). 2023; 12(4).

PMID: 37106705 PMC: 10135860. DOI: 10.3390/biology12040504.


Drug repositioning: doxazosin attenuates the virulence factors and biofilm formation in Gram-negative bacteria.

Elfaky M, Elbaramawi S, Eissa A, Ibrahim T, Khafagy E, Ali M Appl Microbiol Biotechnol. 2023; 107(11):3763-3778.

PMID: 37079062 DOI: 10.1007/s00253-023-12522-3.